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Abstract Thalassaemia and sickle cell disease have been
recognized by the World Health Organization as important
inherited disorders principally impacting on the popula-
tions of low income countries. To create a national and
regional profile of b-thalassaemia mutations in the popu-
lation of India, a meta-analysis was conducted on 17
selected studies comprising 8,505 alleles and offering near-
national coverage for the disease. At the national level 52
mutations accounted for 97.5% of all b-thalassaemia
alleles, with IVSI-5(G[C) the most common disease allele
(54.7%). Population stratification was apparent in the
mutation profiles at regional level with, for example, the
prevalence of IVSI-5(G[C) varying from 44.8% in the
North to 71.4% in the East. A number of major mutations,
such as Poly A(T[C), were apparently restricted to a par-
ticular region of the country, although these findings may
in part reflect the variant test protocols adopted by different
centres. Given the size and genetic complexity of the
Indian population, and with specific mutations for b-thal-
assaemia known to be strongly associated with individual
communities, comprehensive disease registries need to be
compiled at state, district and community levels to ensure
the efficacy of genetic education, screening and counselling
programmes. At the same, time appropriately designed
community-based studies are required as a health priority
to correct earlier sampling inequities which resulted in the
under-representation of many communities, in particular
rural and socioeconomically under-privileged groups.
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Introduction
With an estimated 1,171 million inhabitants, India is sec-
ond only to China in population numbers and currently
accounts for over 17% of the global population (PRB
2009). Unlike China where some 90% of the population are
of Han origin (Black et al. 2007), India has multiple geo-
graphical, ethnic, religious and language divisions (Bittles
2002). As the peoples of India have traditionally married
and reproduced within these sub-divisions, major problems
are encountered in estimating the impact of genetic disease
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at national, regional, state or even local levels. Data of this
nature are, however, essential as despite the current
national infant mortality rate of 55/1000 (PRB 2009), there
is an increasingly rapid transition in the burden of disease
across all age groups from a primarily communicable to a
non-communicable pattern, with non-communicable dis-
eases already estimated to account for 42% of deaths
(Census of India 2001–2003).
The haemoglobinopathies typify these issues. It has
been estimated that the prevalence of pathological
haemoglobinopathies in India is 1.2/1,000 live births
(Christianson et al. 2006), and with approximately 27
million births per year (PRB 2009) this would suggest the
annual birth of 32,400 babies with a serious haemoglobin
disorder. Within this overall disease classification a 1989
WHO Working Group on guidelines for the control of
haemoglobin disorders estimated a 3.9% carrier frequency
for b-thalassaemia in India, encompassing all types of
b-thalassaemia trait (WHO 1989). This estimate was
mainly derived from data collected prior to 1984 and
relied on basic haematological methods of analysis sup-
plemented by information sourced from Livingstone
(1985). However, in the absence of more comprehensive,
quantitative epidemiological information it continues to
be widely cited as the baseline national prevalence for
b-thalassaemia in India.
A WHO update on b-thalassaemia in India indicated a
similar overall carrier frequency of 3–4%, which given the
current national population would translate to between 35.1
and 46.8 million carriers of the disorder nationwide (WHO
2008; PRB 2009). At the same time, a screening project
based on 56,814 college students and pregnant women
recruited in the states of Maharashtra, Gujarat, Punjab,
Karnataka, West Bengal and Assam indicated a carrier rate
of 2.78% (Mohanty et al. 2008). These different carrier
frequency estimates have been used to approximate the
numbers of new affected births per year, which have been
calculated to range from 10,000 to 15,000 cases (Edison
et al. 2008; Sheth et al. 2008; Tamhankar et al. 2009), of
which 8,000–10,000 would present with a severe form of
the disease (Colah et al. 2009). If accurate, the figures
would indicate a cumulative total of 100,000 children with
thalassaemia major in India (WHO 2008).
Unfortunately, there are no adequately representative
data sets to confirm or deny these approximations, and with
50,000–60,000 strictly endogamous communities in India
(Gadgil et al. 1998), it is dubious whether any average
disease prevalence estimate could realistically be applied to
each and every community and sub-population. This con-
tention is supported by estimates that the carrier frequency
for b-thalassaemia ranges from 0.3 to 17% in different
local communities (Agarwal and Mehta 1982; Weatherall
and Clegg 2001; WHO 2008).
The initial studies on b-thalassaemia in Indian popula-
tions were undertaken among overseas migrant communities
and so primarily established the presence of thalassaemia
mutations in individuals from the states of Gujarat and
Punjab, and in the Sindhi community, many of whom orig-
inated in Pakistan (Kazazian et al. 1984; Thein et al. 1988).
Five mutations, IVSI-5(G[C), IVSI-1(G[T), 619-bp del,
Codon 41/42(-TCTT) and Codon 8/9(?G) accounted for
90% of all mutations (Kazazian et al. 1984; Thein et al.
1988). The results were replicated in follow-up collaborative
studies undertaken in Indian and Western centres, mainly
focused on the populations of Gujarat, Punjab and Maha-
rashtra (Varawalla et al. 1991a, 1992; Garewal et al. 1994).
On the basis of these findings it therefore was assumed that in
India the prevalence of b-thalassaemia was highest in the
Sindhi and Punjabi communities, and it was only towards the
end of the twentieth century that reports from other Indian
states demonstrated the wide distribution and extensive
heterogeneity of b-thalassaemia mutations in different
Indian sub-populations.
Given the partial nature of the available information, the
establishment of effective national and regional treatment
and prevention programmes for a disorder such as b-thal-
assaemia is extremely difficult, especially with 229 muta-
tions so far described for the disorder in the locus-specific
HbVar database (Giardine et al. 2007), 184 of which are b?
or b0 mutations (http://globin.bx.psu.edu/hbvar). The pri-
mary aim of the present study was to systematically collate
and critically assess the data so far published on b-thalas-
saemia in India and within the Indian diaspora, and from the
results of this meta-analysis to identify the predominant
causative mutations at national, regional and state levels. In
acknowledgement of the size of the Indian population and
the genetic complexity which follows from the numerous
sub-divisions (Bittles 2002; Reich et al. 2009), attention also
was directed to mutations that to date have been reported as
being largely community-specific in their distribution.
Subjects and methods
The geographical locations of the states and regions of
India are shown in Fig. 1. To minimize undue bias towards
sample collection from individuals of specific geographical
or ethnic origin, and to encourage future more represen-
tative sampling across states and regions, only studies
reporting allelic frequencies for at least 10 b-globin gene
mutations and with a minimum of 50 subjects specifically
identified by their state of origin were selected for inclu-
sion. Seventeen published studies met these criteria and
were accepted for inclusion, with rigorous cross-checking
of data to avoid duplicate entries (Table 1). The informa-
tion on b-globin chain mutations was initially entered by
52 HUGO J (2009) 3:51–62
123
state origin (n = 28), with subsequent collation into six
geographical regions as defined in Fig. 1.
Data were excluded from the analysis where information
on the regional, state or community origins of subjects was
unclear, including 1,150 alleles omitted from persons
identified only as being of Sindhi or Punjabi origin but
lacking any other identifying details (Supplementary
Information, S1). The mean IVSI-5(G[C) allele frequency
among these excluded individuals was just 12.7%, com-
pared with the national average figure of 54.7%, raising
major doubts as to their provenance. Results from the seven
Union Territories, the Andaman and Nicobar Islands,
Fig. 1 Map of India by state
and region
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Chandigarh, Dadra and Nagar Haveli, Daman and Diu,
Delhi, Lakshadweep, and Pondicherry also were excluded
because of the mixed and highly mobile populations in
Delhi, the national capital, and Chandigarh the joint capital
of the states of Punjab and Haryana, and the local and
numerically small populations of the other five Territories.
Only 46 alleles were reported for the populations of the
Northeast region, which comprises eight individual states
with a combined population of 39.0 million (Census of
India 2001a), and is home to many tribal communities of
Tibeto-Burmese origin. Of these Northeast samples 34
(73.9%) of alleles were IVSI-5(G[C) while the remaining
12 alleles consisted of five rare mutations and two
uncharacterized alleles. Given the small and unrepresen-
tative number of alleles tested, the Northeast data were not
separately presented by region in Table 1 and Fig. 2, but
the results were incorporated into the All-India data
analysis.
As might have been expected in studies conducted over
an extended time period, the methods of genomic analysis
employed in the 17 studies varied quite widely and
included gap-polymerase chain reaction (PCR), denaturing
gradient gel electrophoresis (DGGE), temporal temperature
gel electrophoresis (TTGE), amplification refractory
mutation system (ARMS), reverse dot blot hybridization
(RDB), and direct DNA sequencing (Varawalla et al.
1991a; Verma et al. 1997; Vaz et al. 2000; Old et al. 2001;
Agarwal et al. 2003; Bashyam et al. 2004; Sheth et al.
2008; Edison et al. 2008; Colah et al. 2009). For this rea-
son, some variability may inadvertently have resulted in
the mutation profiles reported by individual study centres.
Results
National profile of b-thalassaemia mutations
Information on 8,505 alleles was collated, with 64 b-globin
gene mutations causing b-thalassemia identified in the
Indian population. The profile of the 52 most prevalent and
Table 1 Profile of studies included in the meta-analysis of b-thalassaemia mutations in India
Region State(s) Study
period
Study population No of subjects
(alleles)
Reference
All India 12 of 28 states 1992–1998 Referral 1,228 (1,228) Vaz et al. (2000)
12 of 28 states 1997–2006 Referral 1,029 (1,544) Edison et al. (2008)
12 of 28 states 1995–2007 Referral and screening
programmes
2,089 (2,089) Colah et al. (2009)a
West Gujarat, Maharashtra,
other non-West
Not stated Referral 269 (269) Varawalla et al. (1991a)b
Gujarat Not stated Referral 248 (248) Sheth et al. (2008)
North Punjab, other non-North 1991–1993 Referral 124 (195) Garewal et al. (1994)
Punjab, Haryana, Uttar Pradesh,
Other North, Other non-North
Not stated Referral 474 (474) Verma et al. (1997)c
Uttar Pradesh 1988–1998 Referral 376 (376) Agarwal et al. (2000b)
Punjab 1998–2002 Referrals 176 (352) Garewal and Das (2003)
Uttar Pradesh, Punjab,
Other non-North
1998–2002 Referral 328 (328) Gupta et al. (2003)
Punjab 1998–2004 Referral 35 (88) Garewal et al. (2005)
Uttar Pradesh 2003–2007 Referral and field study 578 (626) Tamhankar et al. (2009)
East West Bengal 1995–1998 Referral and field study 291 (221) Das et al. (2000)d
West Bengal Not stated Referral 60 (80) Kukreti et al. (2002)
West Bengal, Jharkand, Orissa,
Other Northeast
2000–2003 Referral 63 (110) Bandyopadhyay et al. (2004)d,e
South Andhra Pradesh, Karnataka,
Other non-South
2001–2003 Referral 77 (77) Bashyam et al. (2004)d
Andhra Pradesh 2005–2007 Referral 190 (200) Munshi et al. (2009)d
Data deemed ineligible for the study are separately presented in Supplementary Information (S1). They comprise
a 291 subjects listed as ‘immigrants’
b 167 subjects listed as North West Pakistan and 142 as ‘Punjab’
c 53 subjects listed as Pakistan (Sindh)
d Homozygous and heterozygous HbE subjects, and HbE alleles from HbE thalassaemia cases
e 1 subject and 650 chromosomes of ambiguous geographical origins
54 HUGO J (2009) 3:51–62
123
widespread disease alleles, representing 97.5% of the total
b-thalassaemia alleles reported at national level, is por-
trayed by region from the 30 to 50 end of the b-globin gene
(Fig. 2). Equivalent information on the b-globin mutations
identified at individual state level is reproduced in Sup-
plementary Information (S2).
The ten most common b-thalassaemia mutations repor-
ted for All-India and by region are listed in Table 2.
Nationally, IVSI-5(G[C) was the single most common
mutant allele and represented 54.7% of all b-thalassaemia
mutations reported. IVSI-5(G[C), 619-bp del, IVSI-
1(G[T), Codon 41/42(-TCCT) and Codon 8/9(?G)
comprised the five most common disease mutations at the
national level and totalled 82.5% of all mutations, with
Codon 15(G[A), Codon 30(G[C), Cap site ?1(A[C),
Codon 5(-CT) and Codon 16(-C) accounting for an
additional 11.0% of all mutant alleles (Table 2).
It is important to note that 47.0% of the alleles analysed
nationally were from subjects who originated either in the
western states of Maharashtra and Gujarat or the northern
state of Punjab. Furthermore, 15.8% of the national
b-thalassaemia allele profile describes persons specifically
identified as belonging to Sindhi or Punjabi ethnic groups,
which collectively account for just 3.1% of the total pop-
ulation of India (Census of India 2001b). Therefore, as
discussed below in terms of regional mutation profiles,
over-sampling of these groups significantly influenced the
national b-thalassaemia mutation profile reported in pre-
vious studies. To complete the national profile of the
b-thalassaemia mutations so far described in India the
remaining 12 alleles, a number of which have been
reported in one or several subjects only, are listed in
Table 3.
Regional profile of b-thalassaemia mutations in India
The percentage distribution of five representative b-thal-
assaemia mutations is illustrated in Fig. 3 according to
state of origin. IVSI-5 (G[C) accounts for 54.7% of all
b-thalassaemia alleles nationally, and the majority of sub-
jects with this mutation originate from or are resident in the
major states of Maharashtra and Gujarat (West region),
Uttar Pradesh (North region) and West Bengal (East
region). Codon 15 (G[A) also has widespread national
distribution but with 35.3% of all subjects resident in
Maharashtra. The high percentage of -88(C[T) alleles in
cases from Punjab (74.3%) can be ascribed to the fre-
quency of this mutation in the Jat-Sikh community
(Garewal et al. 2005). Likewise, the high prevalence of
Codon 5(-CT) in Gujarat (79.7%) is associated with the
Lohana and Prajapti communities in that state (Sheth et al.
2008). Although the Poly A(T[C) allele has been reported
in the populations of nine states, 65.6% of cases were




































































































































































































































































































































































































































































































































































Fig. 2 Regional distributions of the most common b-thalassaemia alleles in India (n = 52)
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Tamil Nadu and Karnataka (Edison et al. 2008; Colah et al.
2009).
The West region, comprising the major states of
Maharashtra, Gujarat and Rajasthan and the small state of
Goa, had a combined population in 2001 of 205.4 million
(Census of India 2001a). The West is the most widely
represented region in terms of sampling with 3,238 alleles
analysed (38.1% of the total sample), and IVSI-5(G[C)
accounts for 50.7% of all b-thalassaemia mutations.
However, the West region deviates from the national pat-
tern of five common mutations in the somewhat higher
prevalence of the 619-bp deletion (14.2%) and IVSI-
1(G[T) (8.7%), and with Codon 15(G[A) as the fourth
commonest regional mutation with a frequency of 7.6%.
The North region is genetically heterogeneous and
ranges from Uttar Pradesh on the Gangetic Plain in the east
to Punjab, the westernmost state which adjoins the Paki-
stani province of Punjab. Haryana with a large agricultural
community of Jats, and the Himalayan states of Himachal
Pradesh, Uttarakhand and Jammu and Kashmir are the
remaining four states in the region. No data are available
from Jammu and Kashmir because of ongoing civil unrest.
Sampling across the region was non-uniform. Of the 2,484
alleles reported (29.2% of the total sample), 997 were
Table 2 National and regional frequencies (%) of the most common b-thalassaemia mutations in India
 All India West North Central South East 
       
       
IVSI-5(G>C) 54.7 50.7 44.8 49.8 67.9 71.4
619-bp deletion 10.0 14.2 13.0 16.6 1.8 0.4
IVSI-1(G>T) 6.2 8.7 8.6 8.9   
Codon 41/42(-
TCTT) 6.1 5.2 10.3 5.0 2.3 4.3
Codon 8/9(+G) 5.5 4.3 11.0 7.3 0.7 2.1
Codon 15(G>A) 5.5 7.6 1.6 3.5 8.8 5.4
Codon 30(G>C) 2.6 2.0 1.8 2.7 1.7 5.8
Cap site +1(A>C) 1.2 1.1 2.3 1.5   
Codon 5(-CT) 0.9 2.1     
Codon 16(-C) 0.8 0.8 0.6 1.5 0.6 0.9
 -88 (C>T)   2.5    
Codon 15(-T)      0.5
 -90 (C>T)      0.8
Poly A site(T>C)     4.7 0.4
IVSI-1(G>A)    0.8   
IVSII-837(T>G)     3.0
 -28(A>G)     2.2
Others/unknown 6.5 3.3 3.5 2.4 6.3 8.0 
       
Population
(millions)* 1,028.6 205.4 236.4 81.2 223.3 226.9 
Numbers of alleles 
analysed** 8,505 3,238 2,484 259 1,068 1,410 
       
       
       Mutation frequency    
  >50%    
  20-50%      
  5-19%     
  1-4%      
  <1%      
  
*Based on the 2001 Census of India.  Data for the Northeast region not represented 
**Alleles from the Northeast region (n = 46) included in All India analysis 
56 HUGO J (2009) 3:51–62
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obtained from residents of the state of the Punjab which has
a population of 24.3 million, as opposed to the 1,368 alleles
representing the 166.1 million strong population of Uttar
Pradesh. Although IVSI-5(G[C) accounts for just 44.8%
of b-thalassaemia alleles the five most common mutations
reported closely match the national pattern, probably due to
the high representation of samples from Punjab, but with
Codon 16(-C) and -88(C[T) in the list of ten common
mutations along with Codon 15(G[A), Codon 30(G[C)
and Cap site ?1(A[C).
The Central region consisting of the quite sparsely
populated states of Madhya Pradesh and Chhattisgarh is
grossly under-represented with only 259 reported alleles.
Importantly, the Central region is home to many indige-
nous Scheduled Tribes which in the 2001 Census of India





























































Fig. 3 Percentage distributions of five illustrative b-thalassaemia mutations at state level
Table 3 Less common
b-thalassaemia mutations
reported in the population of
India
Mutation State or community of origin Reference
-87(C[G) Uttar Pradesh Agarwal et al. (2006)
IVSII-591(T[C) Uttar Pradesh Agarwal et al. (2000a)
Codon 8(A[G) Uttar Pradesh Agarwal et al. (1999)
Codon 13(C[T) Uttar Pradesh Agarwal et al. (2000a)
Codon 27/28(-C) Uttar Pradesh Agarwal et al. (2000a)
Codon 5(C[T) Uttar Pradesh Agarwal et al. (2000a, 2000b)
Codon 4(T[A) Uttar Pradesh Agarwal et al. (2000a, 2000b)
Codon 57/58(?C) Sikh el-Kalla and Matthews (1995)
Codon 26(G[T) Maharashtra, Karnataka Edison et al. (2008); Colah et al. (2009)
IVSII-745(C[G) Tamil Nadu Colah et al. (2009)
IVSI-5(G[T) Sindhi Sheth et al. (2008)
Cd88(?T) Not specified Varawalla et al. (1991b)
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million, and with another 13.4% of the population
belonging to Scheduled Castes. There is no evidence that
either of these predominantly rural and impoverished
communities is represented in the regional data set
analysed.
Four states Andhra Pradesh, Karnataka, Tamil Nadu and
Kerala make up the South region which has a predomi-
nantly Dravidian population, ethnically and culturally quite
distinct from the largely Indo-European populations of
northern, central and western India that represent later
population flows into the Indian sub-Continent (Reich et al.
2009). In the 2001 Census of India 20.8% of people
countrywide indicated a Dravidian mother tongue, which
closely parallels the 21.7% of the national population res-
ident in the South region. IVSI-5(G[C) has a prevalence of
67.9% in the South, suggesting that it may have been the
ancestral mutation in the Dravidian founder population of
the sub-Continent. The other five and ten most common
disease alleles in the South region differ significantly from
the overall national pattern; the 619-bp deletion is present
in only 1.8% of cases, whereas Codon 15(G[A) is the
second most common southern disease allele (8.8%), Poly
A site (T[C) is the third most common allele (4.7%) and in
6.3% of cases the disease mutation is rare or unknown.
The East region exhibited by far the highest prevalence
of IVS I-5(G[C) at 71.4%, with Codon 30(G[C) and
Codon 15(G[A) the second and third most common
alleles, accounting for 5.8% and 5.4% of the total respec-
tively, followed by Codon 41/42-TCCT) with a preva-
lence of 4.3%. The data for the East region are mainly
drawn from West Bengal, with the other three constituent
states, Bihar, Jharkhand and Orissa, contributing just 311
alleles to the regional total of 1,410 disease alleles. As in
the South region there are a large number of alleles (8.0%)
which are rare or unknown nationally, probably indicative
of the substantial Scheduled Tribal populations in Jhark-
hand (26.3%) and Orissa (22.1%), the Scheduled Caste
communities in West Bengal (23.1%) (Census of India
2001c), and very substantial population movement into the
region from Bangladesh (formerly East Pakistan) to the
east, during and following the Independence of India in
1947 and the establishment of Bangladesh in 1971.
Discussion
Although it is estimated that more than 300,000 babies are
born each year with a major inherited haemoglobin disor-
der (Christianson et al. 2006) and the lives of many mil-
lions of children, adolescents and adults are adversely
affected, until quite recently these diseases were rarely
included in the health priorities of national governments or
international health agencies (Weatherall and Clegg 2001).
This situation changed in 2006 with recognition by the
Executive Board of the World Health Organization that
thalassaemia and sickle cell anaemia were major global
health problems which needed to be urgently addressed
(WHO 2006), a move reinforced by their inclusion in the
current Global Burden of Disease Study (http://global
burden.org).
Given the demonstrated high frequency of b-thalassae-
mia alleles in India and the immense size of the national
population, the present study is necessarily preliminary and
any conclusions drawn need to be assessed in that light. As
previously noted, with a total population of 1,171 million
and a rate of natural population increase of 1.6% (PRB
2009), collecting accurate and representative health infor-
mation in India is a major problem. The highly endoga-
mous nature of Indian society, traditionally based on castes
which claim long and unbroken genealogical histories,
means that each community effectively functions as a
separate breeding pool, with the consequent probability
that recent mutations may be unique to single communities
(Bittles 2008, 2009; Bittles and Black 2010). Representa-
tive sampling can therefore become extremely difficult,
given the population stratification that results from the
multiple ethnic, social and religious subdivisions which are
a central facet of everyday existence.
When dealing with an autosomal recessive disorder such
as b-thalassaemia, an additional important factor that has to
be considered is the widespread preference for intra-
familial unions in the southern Dravidian states of Andhra
Pradesh, Karnataka and Tamil Nadu, where 30?% of
marriages are consanguineous, mainly uncle-niece
(F = 0.125) or first cousin (F = 0.0625), and with sub-
stantial levels of consanguineous unions in neighbouring
Kerala and southern Maharashtra (Bittles et al. 1991; Bit-
tles 2002; www.consang.net). In these states it would be
expected that a high proportion of b-thalassaemia cases
would be homozygous for the causative mutation, and
indeed 98% of affected subjects investigated in Andhra
Pradesh were homozygotes for a specific mutant allele
(Bashyam et al. 2004).
At first sight the situation might be considered different
in the other regions of India where exogamy in the Hindu
population is practised at gotra level, i.e. involving
extended male lineages, but with marital endogamy at caste
level. However, since an overwhelming percentage of
marriages continue to be contracted on an intra-caste and
intra-community basis, even though spouses may not be
known to be biologically related, there is a very strong
chance that they have a large proportion of their genes in
common (Bittles 2008). Thus, even in West, North, and
East India, a higher than expected proportion of patients
with b-thalassaemia probably are homozygous for a single
mutant allele rather than being compound heterozygotes.
58 HUGO J (2009) 3:51–62
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This probability is increased by the high frequency of the
IVSI-5(G[C) mutation in each region (Table 2), and by the
15.8% to 33.0% prevalence of consanguineous marriage at
state level in the large Muslim minority population (Bittles
and Hussain 2000).
The prevailing wisdom has been that b-thalassaemia in
India principally affects the Sindhi, Gujarati, Bengali,
Punjabi and Muslim communities (Agarwal 2005), although
this supposition has been strongly influenced by the more
extensive testing undertaken in these sub-populations. As a
large majority of communities have yet to be sampled,
especially among the Scheduled Castes and Scheduled
Tribes and the group of lower caste communities collec-
tively defined by the Government of India as Other Back-
ward Classes, this opinion may well require significant
future revision, and it seems highly probable that previously
uncharacterized mutations remain to be identified. In the
interim, it is important that public education programmes, in
combination with opportunities for premarital and prenatal
screening, should be made available to as wide a range of
couples, families and communities as possible.
Table 2 showed that while IVSI-5 (G[C) was the pre-
dominant mutation throughout India, the prevalence varied
from 44.8% in the North to 71.4% in the East. It also was
apparent from Table 2 and Fig. 3 that the profile of other
mutations showed significant inter-regional variation, to
the extent that this variation merited serious consideration
in the design and implementation of future screening pro-
grammes. The higher the mutation detection rate with as
small a number of markers employed, the more efficient
the testing protocol will be in terms of staff time expended
and the costs involved.
As summarized in Table 4, this type of approach already
appears feasible at regional level. Importantly, testing for
the five most common mutations at national level would
detect 82.5% of cases, and for the ten most common
mutations 93.5% of cases would be identified. But by
changing the testing protocols to incorporate the most
appropriate mutation profiles identified at regional level,
the potential levels of detection could be increased to
87.7% (North) for the five most common mutations, and
97.6% (Central) for the ten most common b-thalassaemia
mutations. Given the size of the potential b-thalassaemia
case-load in India, due accommodation for these differ-
ences in the potential efficiency of screening programmes
could produce substantial savings in both time and costs.
Could this level of performance be further improved if
community-based rather state or regional mutation data were
available? To answer this question, previously unreported
data on 1,031 b-thalassaemia alleles in the large northern
state of Uttar Pradesh (S Agarwal, unpublished) were
examined in a separate analysis. As indicated in Table 5 the
results have been subdivided into seven categories, corre-
sponding to the main religious, caste and socioeconomic
subdivisions within the population of the state.
The ten most common b-thalassaemia mutations identi-
fied are as listed for the North region in Table 2. Although
the numbers within each sub-division are small and signif-
icant mutation overlap exists between a number of the
communities, such as the Hindu upper caste Brahmins and
Kshatriyas, there also are major differences in community
mutation profiles, e.g., comparing the Brahmin community
in which Cap Site ?1(A[C), IVSI-5 (G[C) and Codon 41/
42(-TCTT) are the three most common diseases alleles,
with the communities classified as Other Backward Classes
where ‘Other mutations’, Codon 16(-C), IVSI-5(G[C),
and Codon 15 (G[A) alleles predominate.
There also is clear evidence of over-sampling of eco-
nomically more privileged groups. Thus while the four
Hindu upper and middle castes, the Brahmins, Kshatriyas,
Vaishyas and Kayasthas comprise *19% of the population
of Uttar Pradesh they account for 56.8% of the b-thalas-
saemia alleles tested, whereas the Hindu Other Backward
Classes who form *31% of the total state population
(NSSO 2005) comprised just 11.4% of alleles.
From a genetic screening and genetic counselling per-
spective the data do indicate that community-specific
mutation profiles could be highly effective in helping to
screen for and prevent b-thalassaemia. At the same time it
has to be acknowledged that to establish similar commu-
nity-specific mutation profiles throughout India would be
an extremely difficult logistic task within the near future.
But the potential benefits are very high in health, social and
economic terms, and the creation of more detailed dat-
abases of b-thalassaemia alleles will facilitate better
focused, more efficient, and cost-effective testing and
treatment protocols that can concentrate on individual
communities and sub-populations.
Conclusions
The outcomes derived from the basic data collated in the
present study should provide a sound platform on which
future health care planning for the prevention and treatment
Table 4 National and regional frequencies (%) of the five and ten
most common b-thalassaemia mutations in India
All
India
West North Central South East
Five most common
mutations
82.5 86.4 87.7 87.6 86.7 89.0
Ten most common
mutations
93.5 96.7 96.5 97.6 93.7 92.0
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of b-thalassaemia in India can be undertaken. The need for
a paradigm shift in b-thalassaemia-related research is,
however, indicated. While determination of the broad-
based geographical distribution of causative mutations has
been an important initial step, there is a clear need for
structured sampling programmes to be planned and insti-
tuted to provide representative information on regions,
such as Central India and the Northeast, for which data are
currently inadequate. Additionally, in a country with a
population as large and ethnically and socially diverse as
India, the further extension of sampling to facilitate state,
district and village registers of persons with b-thalassaemia
and carriers of the disorder is warranted (WHO 2008).
Indeed, given the continuing marked hereditary sub-divi-
sions within Indian society that result from intra-caste and
intra-community marriage, community-specific mutation
testing would provide the basis for the optimum delivery of
genetic education, screening and prevention programmes.
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